Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$651,838,132
+$49,780,457 QoQ
Shares Held
2,566,595
+4.2% QoQ
Ownership
0.107%
of shares outstanding
% of Portfolio
0.92%
of 13F equity value
Holder Rank
#83
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ADAGE CAPITAL PARTNERS GP, L.L.C. holds $2,791,248,361 across 11 Drug Manufacturers - General names. JNJ ranks #2 (23.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
726,199 | $871,024,939 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
2,566,595 | $651,838,132 | |
| 3 | ABBV |
AbbVie Inc.
|
1,598,568 | $402,263,651 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,030,023 | $260,857,955 | |
| 5 | AMGN |
Amgen Inc
|
471,833 | $170,860,165 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,071,977 | $135,433,574 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
1,716,000 | $98,875,920 | |
| 8 | PFE |
Pfizer Inc
|
3,801,302 | $91,535,352 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $651,838,132 | 2,566,595 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $602,057,675 | 2,463,008 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $457,548,445 | 2,210,913 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $419,727,280 | 2,263,657 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $204,161,067 | 1,336,570 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $212,014,333 | 1,278,427 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $135,191,065 | 934,802 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $262,399,286 | 1,619,149 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $124,604,615 | 852,522 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $158,404,663 | 1,001,357 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $153,782,943 | 981,134 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $214,359,192 | 1,376,303 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $244,675,470 | 1,478,223 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $195,303,565 | 1,260,023 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $284,301,569 | 1,609,406 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $338,675,828 | 2,073,187 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $389,807,522 | 2,195,975 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $373,706,291 | 2,108,595 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $322,962,197 | 1,887,895 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $428,549,940 | 2,653,560 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $349,843,511 | 2,123,610 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $373,141,883 | 2,270,410 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $222,757,225 | 1,415,410 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $253,425,024 | 1,702,210 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $77,038,520 | 547,810 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $307,671,630 | 2,346,310 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||